At 2–5% w/w of dry granulate mass, oleoyl macrogolglycerides veterinary grade is sprayed molten at 40–45°C onto a lactose monohydrate and microcrystalline cellulose carrier in a 25 L high-shear mixer. The material is not added as a dry powder in this route; the semi-solid state at ambient temperature makes direct blending difficult, and pump-heated transfer lines are required to maintain a viscosity below 500 mPa·s during spray application. The granulation endpoint is detected by an impeller power rise of 0.8–1.5 kW. Tablets compressed on a 16-station rotary press at 8–14 kN show friability less than 0.5% measured by Ph. Eur. 2.9.7 when granule moisture is held between 1.8% and 2.4% by Ph. Eur. 2.2.32. Disintegration, tested by Ph. Eur. 2.9.1, remains below 15 min for immediate-release oral boluses. The main production failure mode is capping at press speeds above 45 rpm when lipid addition exceeds 6% w/w; hard, hydrophobic granules reduce tensile strength below 40 N, and ejection force rises by 0.6–1.0 kN, generating high friability at the batch tail. Uniformity of content is evaluated by Ph. Eur. 2.9.40; an acceptance value below 15% is required for uncoated veterinary tablets. Oleoyl macrogolglycerides should not be used as the sole binder for highly water-soluble active salts because the lipid film retards deaggregation, and dissolution may fall below 75% at 30 min under USP <711> in 0.1 N HCl for poorly wetting formulations.

What Limits Terminal Sterile Filtration in Injectable Formulations?

Oleoyl macrogolglycerides veterinary grade is used at 1.0–3.0% w/w as a nonionic emulsifier and co-solvent in oil-in-water injectable systems for hydrophobic actives with log P above 4. The component self-associates above its critical micellar concentration, typically 0.01–0.05% w/w for the shorter macrogol-chain grades. Micelle aggregation near the cloud point causes irreversible fouling of 0.22 µm polyethersulfone membranes; terminal sterile filtration must therefore be preceded by a 0.45 µm prefilter at 30–35°C and a differential pressure not exceeding 0.8 bar. Filter validation follows ISO 13408-1:2016 for aseptic processing of health care products, with bacterial retention confirmed using Brevundimonas diminuta at 10⁷ CFU/cm². Sterility is performed by Ph. Eur. 2.6.1, and subvisible particulate matter is controlled to ≤600 particles/container for particles ≥25 µm and ≤6,000 particles/container for particles ≥10 µm in large-volume parenterals under Ph. Eur. 2.9.19. Autoclaving at 121°C for 15 min is not recommended as the preferred route because peroxide values may exceed 10 mEq/kg, leading to oxidation of unsaturated fatty acid residues and visible turbidity. Where terminal heat sterilisation is unavoidable, nitrogen gassing and the addition of 0.05% w/w α-tocopherol are used; however, the antioxidant amount must not mask the peroxide endpoint during stability. Published in vivo bioavailability data for this specific veterinary injectable configuration are limited, so pilot filterability trials at 1:10 scale with the target batch volume are required before scale-up.

Oleoyl Macrogolglycerides Enters the Granule Structure but Delays Disintegration

The addition of 3–7% w/w oleoyl macrogolglycerides to a wet mass containing microcrystalline cellulose and lactose monohydrate lowers extrusion torque from 11–14 N·m to 7–9 N·m in a twin-screw extruder with an L/D 20:1 barrel and screw speed of 60–120 rpm. The lipid acts as a plasticiser at the solid-liquid interface, reducing water demand by 2–4% relative to a control granulation without the excipient. Spheronization is performed on a 40 cm radial plate spheronizer at 800–1,000 rpm for 3–5 min; the target granule fraction is 850–1,180 µm, and sieve yield above 80% is achievable when the extrudate surface remains dull and non-tacky. Drying temperature is the controlling threshold: above 45°C, oleoyl macrogolglycerides migrates to the granule surface, producing sticky fines, bridging in the dryer, and oversize agglomerates. A fluid-bed dryer inlet temperature of 40±2°C with final moisture below 2.0% by Ph. Eur. 2.2.32 preserves particle size distribution. Disintegration of the finished granules is typically slower than carbohydrate-based granules because the lipid matrix retards water penetration; release of a poorly soluble active can shift from immediate to prolonged over 4–8 h depending on granule porosity. Particle-size distribution is evaluated by Ph. Eur. 2.9.38, bulk density by Ph. Eur. 2.9.34, and loss on drying by Ph. Eur. 2.2.32. The granules are packed into sachets or administered as feed top-dressing; packaging must have a moisture vapour transmission rate below 0.1 g/m²/day at 38°C and 90% RH to prevent the lipid from softening at high humidity.

For soft gelatin capsules, a fill matrix containing oleoyl macrogolglycerides at 20–40% w/w blended with medium-chain triglycerides and propylene glycol monocaprylate reduces precipitation of neutral active on dilution in simulated gastric fluid. The melt viscosity at 35°C should be held between 150 mPa·s and 1,000 mPa·s for rotary-die filling on a 9-inch rotary die machine; below 150 mPa·s, fill leakage between the shell halves increases, while above 1,000 mPa·s, fill weight variance exceeds ±2.5%. Gelatin shell brittleness becomes relevant at low relative humidity: when RH falls below 40%, macrogol glycerides can migrate from the fill into the shell and plasticise gelatine, but incomplete distribution leads to seam cracking and shell rupture during blistering. Shell formulations should therefore include 5–10% w/w glycerol or sorbitol plasticiser. Disintegration is tested by Ph. Eur. 2.9.3; fill release is expected within 15 min in 0.1 N HCl at 37±2°C. Residual solvents are controlled by VICH GL18, and assay of the active after encapsulation is performed by HPLC with column temperature maintained at 40°C to prevent lipid precipitation in the diluent. For hard gelatin capsules, oleoyl macrogolglycerides is not generally added above 5% w/w to powder blends because the semi-solid character at storage temperatures above 30°C causes powder bed collapse and variable fill weights. The main production failure is incomplete fill bridging in dosator nozzles when the blend temperature exceeds 28°C; air conditioning of the encapsulation room to 20–24°C and 40% RH is required. Published data for this specific formulation configuration are limited, but viscosity and dissolution thresholds are established by standard capsule monograph methods.

Powder and Premix Carriers for Drinking Water and Feed Medication

In water-soluble powders intended for swine and poultry drinking water, oleoyl macrogolglycerides is first adsorbed onto precipitated silica at a ratio of 30 g excipient per 100 g silica to prevent sticky agglomerates during storage. The loaded silica is then blended with active compound, dextrose monohydrate, and citric acid in a double-cone blender at 15 rpm for 20 min. Final moisture is kept below 0.5% by Ph. Eur. 2.2.32; above this value, the semi-solid lipid bridge fuses powder particles and produces non-dispersible lumps in the mixing tank. The reconstituted solution is prepared at 0.1–0.5 g/L in drinking water at 20±2°C and must remain uniformly dispersible for 24 h; hardness above 250 mg/L CaCO₃ reduces the cloud point by 10–15°C and can cause surface oiling. The inclusion of citric acid at 0.02–0.1% w/w buffers the water to pH 5.0–6.5 and improves repeatability. For medicated feed premix manufacture, oleoyl macrogolglycerides is incorporated at 10–25% w/w into a plowshare mixer as a dust-binding lipophilic carrier; the sequence is to add the liquid lipid fraction over a 5–8 min period after the macro-ingredients have mixed for 10 min, preventing localized agglomerates. Homogeneity of the premix is tested by VICH GL24 or equivalent, and the content of active in 3 separate samples should not exceed a coefficient of variation of 5%. Carryover limits in feed mills are implemented under Regulation (EU) 2019/4, with flush-out procedures after batches containing the premix. The final pelleted feed should be processed below 75°C at the conditioner exit to avoid peroxide formation; measured peroxide value should remain below 5 mEq/kg by Ph. Eur. 2.5.36. Production belt cleaning with warm alkali detergent removes residual lipid from the mixer, but stainless steel contact surfaces should not be left wet, as free oleic acid residues accelerate pitting.

When Oleoyl Macrogolglycerides Replaces Polysorbate 80 in Oral Solutions for Poultry

Oral solutions and drinking water formulations use oleoyl macrogolglycerides veterinary grade at 0.5–2.0% w/v as a solubiliser for active compounds with aqueous solubility below 0.1 mg/mL. Compared with polysorbate 80, the more lipophilic oleoyl core alters the cloud point; in hard water at 250 mg/L CaCO₃, solutions at 2.0% w/v may cloud below 55°C, so dilution rate and water quality must be fixed in the veterinary prescribing information. The compounding sequence is to hydrate the excipient in purified water at 30–35°C under 400–600 rpm propeller stirring; high-shear dispersion above 2,000 rpm should be avoided because it entrains air and accelerates peroxide formation. The pH is adjusted to 4.5–6.5 with citrate buffer, and the finished product is filled into amber high-density polyethylene containers with nitrogen headspace. Clear HDPE is acceptable only if stored below 25°C and protected from light; polyvinyl chloride containers are unsuitable because di(2-ethylhexyl) phthalate migration can be enhanced by the macrogol fraction. Microbiology is controlled by Ph. Eur. 2.6.12 and 2.6.13, with total aerobic microbial count below 10² CFU/mL. End-product assay and related substances are determined by HPLC with evaporative light scattering detection; the mobile phase must contain 60–80% acetonitrile to keep the lipid components in solution. The key incompatibility is with strongly ionic actives; at pH below 4.0, hydrolysis of the ester bonds increases free fatty acid content and produces turbid solutions. Where published data for the specific active are lacking, a factorial compatibility study at 5°C, 25°C, and 40°C over 4 weeks is required before batch release.